1. Stocks
    2. /
  2. CSL (ASX: CSL)
    3. /

CSL (ASX: CSL) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

CSL Chart and Price Data

Fundamentals Data provided by Morningstar.

Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

    • CSL (ASX: CSL)
    Latest News

    ecommerce asx shares represented by santa doing online shopping on laptop
    Healthcare Shares

    Looking for ideas before Christmas? These 2 ASX shares stand out to me

    | Aaron Teboneras

    Two ASX shares at opposite ends of the market are catching my attention as the year draws to a close.

    Read more »

    A smiling woman holds a Facebook like sign above her head.
    Blue Chip Shares

    CSL and more blue-chip ASX 200 bargains I'd buy before 2026

    | James Mickleboro

    Here's why I think these shares could be cheap buys before the end of the year.

    Read more »

    A doctor or medical expert in COVID protection adjusts her glasses, indicating growth or strong share price movement in ASX medical, biotech and health companies
    Opinions

    Forget CSL shares, I'd buy this booming biotech stock instead

    | Samantha Menzies

    This ASX biotech stock has caught my eye this year.

    Read more »

    Middle age caucasian man smiling confident drinking coffee at home.
    Broker Notes

    Buy, hold, sell: CSL, Vulcan, Woolworths shares

    | James Mickleboro

    Let's see what analysts are saying about these stocks this week.

    Read more »

    A doctor shrugs and holds his hands out.
    Healthcare Shares

    Down 36% in 2025, should you buy CSL shares today?

    | Bernd Struben

    A leading investment expert offers his outlook for CSL’s beaten-down share price.

    Read more »

    Bored man sitting at his desk with his laptop.
    Share Fallers

    Why ASX, CSL, Galan Lithium, and NextDC shares are dropping today

    | James Mickleboro

    These shares are starting the week in the red. Let's find out why.

    Read more »

    Three guys in shirts and ties give the thumbs down.
    Healthcare Shares

    Why did Macquarie just downgrade CSL shares?

    | James Mickleboro

    The broker has taken an axe to its valuation of this biotech giant.

    Read more »

    Six smiling health workers pose for a selfie.
    Healthcare Shares

    Here are the latest growth forecasts for the CSL share price

    | Tristan Harrison

    Let’s look at what experts are expecting from the healthcare giant in 2026.

    Read more »

    A fresh-faced young woman holds an Australian flag aloft above her head as she smiles widely.
    Cheap Shares

    Buy Australian: ASX stocks positioned to beat global markets next year

    | James Mickleboro

    Let's see why these shares could be destined to outperform in 2026 according to analysts.

    Read more »

    Five people are lunging for the finish line on an athletics track with the picture taken from above as an aerial view of the athletes with their arms outstretched.
    Opinions

    5 ASX 200 shares I'd buy with $10,000 this week

    | Samantha Menzies

    I like the look of these ASX 200 shares.

    Read more »

    man in old fashioned suit and hat looking through magnifying glass
    Blue Chip Shares

    Is the CSL share price a generational bargain at $180?

    | Aaron Teboneras

    CSL shares are currently trading near a 7-year low.

    Read more »

    Buy now written on a red key with a shopping trolley on an Apple keyboard.
    Share Market News

    10 most-traded ASX shares last week

    | Samantha Menzies

    Some new companies joined the top-10 list for the first week of December.

    Read more »

    Frequently Asked Questions

    CSL was listed on the ASX in June 1994.

    CSL has paid twice yearly dividends every year since late 1997, a little over three years after the company’s initial listing on the ASX. Up until early 2005, CSL’s dividends were all fully franked. Since then, franking credits have been intermittent.

    Since 2021 CSL has paid an unfranked interim dividend in April and a 10% franked final dividend in September/October.

    CSL has a dividend reinvestment plan, however, it has not been active since 2004. Instead, CSL periodically executes share buybacks as a way of delivering additional returns for shareholders.

    CSL originally floated in 1994 at $2.30 per share. However, taking into account share buybacks, the adjusted entry price is equivalent to around 76 cents. 

    CSL ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About CSL

    CSL Limited (ASX: CSL) is an Australian-based global biotechnology company that develops and delivers biotherapies and vaccines to protect public health and help people with life-threatening medical conditions live full lives.

    CSL has been in operation for more than a century and was listed on the ASX in 1994. Today, the blue-chip healthcare company is one of the largest on the ASX.

    CSL’s operational businesses include CSL Behring, CSL Seqirus and CSL Vifor. Its Plasma business operates one of the largest plasma collection networks in the world. CSL is recognised for its global leadership in three main areas: rare and serious diseases, vaccine development, and iron deficiency and nephrology (kidney research).

    The company operates in over 40 countries, predominantly Australia, the United States, Germany, the United Kingdom, and Switzerland.

     

    Profile

    since

    Note